In8bio Historical Financial Ratios
| INAB Stock | USD 0.23 0.01 4.17% |
In8bio is lately reporting on over 86 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 1.0 or Days Sales Outstanding of 0.0 will help investors to properly organize and evaluate In8bio Inc financial condition quickly.
In8bio |
About In8bio Financial Ratios Analysis
In8bio IncFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate In8bio investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on In8bio financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across In8bio history.
In8bio Financial Ratios Chart
Add Fundamental
Free Cash Flow Yield
A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.Inventory Turnover
A ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management.Payables Turnover
A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.Most ratios from In8bio's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into In8bio Inc current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in In8bio Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. At present, In8bio's PTB Ratio is projected to decrease significantly based on the last few years of reporting. The current year's PB Ratio is expected to grow to 1.00, whereas Book Value Per Share is forecasted to decline to 0.26.
| 2024 | 2025 (projected) | Payables Turnover | 2.44 | 2.56 | Days Of Inventory On Hand | 51.33 | 45.62 |
In8bio fundamentals Correlations
Click cells to compare fundamentals
In8bio Account Relationship Matchups
High Positive Relationship
High Negative Relationship
In8bio fundamentals Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Ptb Ratio | 10.56 | 2.16 | 2.13 | 1.65 | 0.95 | 1.0 | |
| Book Value Per Share | 0.95 | 2.03 | 1.08 | 0.83 | 0.27 | 0.26 | |
| Free Cash Flow Yield | (0.0369) | (0.17) | (0.57) | (0.58) | (1.76) | (1.67) | |
| Operating Cash Flow Per Share | (0.25) | (0.37) | (0.72) | (1.15) | (0.78) | (0.47) | |
| Pb Ratio | 10.56 | 2.16 | 2.13 | 1.65 | 0.95 | 1.0 | |
| Free Cash Flow Per Share | (0.37) | (0.74) | (1.33) | (0.8) | (0.45) | (0.48) | |
| Roic | (0.46) | (0.37) | (0.91) | (1.02) | (1.56) | (1.64) | |
| Net Income Per Share | (0.44) | (0.78) | (1.31) | (1.0) | (0.57) | (0.6) | |
| Payables Turnover | 0.15 | 0.64 | 0.53 | 2.71 | 2.44 | 2.56 | |
| Cash Per Share | 0.93 | 1.97 | 0.87 | 0.71 | 0.21 | 0.2 | |
| Pocfratio | (27.13) | (6.1) | (2.01) | (1.77) | (0.57) | (0.6) | |
| Pfcf Ratio | (27.13) | (5.97) | (1.74) | (1.72) | (0.57) | (0.6) | |
| Days Payables Outstanding | 2.4K | 574.4 | 691.94 | 134.85 | 155.08 | 147.32 | |
| Income Quality | 0.83 | 0.92 | 0.85 | 0.78 | 0.79 | 1.01 | |
| Roe | (0.47) | (0.38) | (1.21) | (1.2) | (2.1) | (2.0) | |
| Ev To Operating Cash Flow | (24.64) | (3.54) | (1.5) | (1.06) | (0.32) | (0.33) | |
| Pe Ratio | (22.62) | (5.63) | (1.77) | (1.37) | (0.45) | (0.48) | |
| Ev To Free Cash Flow | (24.64) | (3.46) | (1.3) | (1.04) | (0.32) | (0.33) | |
| Earnings Yield | (0.0442) | (0.18) | (0.57) | (0.73) | (2.21) | (2.1) | |
| Net Debt To E B I T D A | 2.1 | 2.4 | 0.45 | 0.57 | 0.2 | 0.19 | |
| Current Ratio | 7.05 | 17.28 | 3.82 | 4.57 | 4.08 | 7.87 | |
| Tangible Book Value Per Share | 0.95 | 2.03 | 1.08 | 0.83 | 0.27 | 0.26 | |
| Shareholders Equity Per Share | 0.95 | 2.03 | 1.08 | 0.83 | 0.27 | 0.26 | |
| Graham Net Net | 0.8 | 1.76 | 0.38 | 0.42 | 0.0869 | 0.0826 | |
| Enterprise Value Over E B I T D A | (20.75) | (3.32) | (1.32) | (0.87) | (0.25) | (0.27) | |
| Price Earnings Ratio | (22.62) | (5.63) | (1.77) | (1.37) | (0.45) | (0.48) | |
| Price Book Value Ratio | 10.56 | 2.16 | 2.13 | 1.65 | 0.95 | 1.0 | |
| Price Earnings To Growth Ratio | (0.36) | (0.0728) | (0.026) | 0.058 | 0.0105 | 0.009997 | |
| Days Of Payables Outstanding | 2.4K | 574.4 | 691.94 | 134.85 | 155.08 | 147.32 | |
| Price To Operating Cash Flows Ratio | (27.13) | (6.1) | (2.01) | (1.77) | (0.57) | (0.6) | |
| Price To Free Cash Flows Ratio | (27.13) | (5.97) | (1.74) | (1.72) | (0.57) | (0.6) | |
| Effective Tax Rate | 0.0132 | 0.0138 | (0.0376) | 0.0387 | 0.0445 | 0.0467 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in In8bio Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of In8bio. If investors know In8bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about In8bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of In8bio Inc is measured differently than its book value, which is the value of In8bio that is recorded on the company's balance sheet. Investors also form their own opinion of In8bio's value that differs from its market value or its book value, called intrinsic value, which is In8bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because In8bio's market value can be influenced by many factors that don't directly affect In8bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between In8bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if In8bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, In8bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.